A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Clinical trial NCT00727961 · COMPLETED

Trial details

NCT number: NCT00727961
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2004-11-09
Primary completion: 2008-01-10
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.